Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
about
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trialHypersensitivity and nanoparticles: update and research trendsAdvances and Challenges of Liposome Assisted Drug DeliveryNanoemulsions in translational research-opportunities and challenges in targeted cancer therapyA Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human PrimatesSpecies differences in tumour responses to cancer chemotherapyPre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyNanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell DeathLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Quantitative Assessment of Inflammation in a Porcine Acute Terminal Ileitis Model: US with a Molecularly Targeted Contrast Agent.Nanoparticles and the immune systemNanoparticles for imaging, sensing, and therapeutic intervention.A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety.NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.Standardization of models and methods used to assess nanoparticles in cardiovascular applications.Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systemsUnexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.Recent developments in liposome-based veterinary therapeutics.Past, Present, and Future of Lipid Resuscitation Therapy.Hypersensitivity to intravenous iron: classification, terminology, mechanisms and managementSilica nanoparticles induce cardiotoxicity interfering with energetic status and Ca2+ handling in adult rat cardiomyocytes.Safety of poly (ethylene glycol)-coated perfluorodecalin-filled poly (lactide-co-glycolide) microcapsules following intravenous administration of high amounts in ratsPilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock.Adipose tissue macrophages in non-rodent mammals: a comparative study.Comparison of epinephrine vs lipid rescue to treat severe local anesthetic toxicity - an experimental study in piglets.Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases.Local anesthetic systemic toxicity and animal models for rescue paradigms: can pigs fly?Localised drug release using MRI-controlled focused ultrasound hyperthermia.Dual-functionalized poly(amidoamine) dendrimers with poly(ethylene glycol) conjugation and thiolation improved blood compatibility.Acute toxicity study of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol, and γ-tocopherol in rats.Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment.Expression and function of C5a receptor in a fatal anaphylaxis after honey bee sting.Low-dose exposure of silica nanoparticles induces cardiac dysfunction via neutrophil-mediated inflammation and cardiac contraction in zebrafish embryos.Utilization of a Swine (Sus scrofa) Model for Lipid Emulsion Resuscitation Studies
P2860
Q21245483-FE774013-5725-4912-8CD4-28A04C20B866Q26752076-93234025-0A66-43A0-9B47-A183207BC267Q26773160-5A98BA28-ABD8-4442-B52C-AFD13545385BQ26858849-F0A32D6C-66E6-4429-89CA-688115EB6E15Q27116692-22892679-BED1-4BC8-9A2A-CE6D91B34FF9Q28080727-B37BAC78-F3D8-4B6E-882A-DFEC0A2C9337Q28081577-732A5D8E-D6FA-44B2-A490-28C86BAD0EAFQ29248384-C2F9C14C-1593-4007-9E8F-68EA83E117DBQ30366990-6F43E89A-CD1E-4AD2-97D9-969ACECD55CBQ30375481-0F21DB10-6F10-4151-A961-EDCE6702CA0DQ33634320-E16FDAD8-D796-4B93-B13F-5BC443426472Q34010233-077D69FD-8752-43E1-83C5-2C8B1BDAF805Q34557766-8A910AC9-777C-4EA9-9E0B-CE32E23B2D1DQ35190356-E2019AE8-BA0F-4E2E-9C33-522E77EC575FQ35975280-3BC49786-AED3-4E7D-A302-6B366528234CQ37354233-90469F88-2E16-44B7-933A-4C380D1AD679Q37841416-8D7507B7-5246-4E63-B5A6-FFAA14EA1EFCQ37942472-4BAE0AB9-BB5E-4251-8C3F-2877FD300D52Q38087506-2A493061-492F-4634-9A11-1976C9B213F9Q38112504-9052A7BA-EE7B-4ECD-881E-47C7EF92C3F4Q38162184-28DAA7F9-AF79-43EF-A3DB-18CE1390EE7BQ38549786-4C45FA56-9735-4D4A-817D-5936B3F1FEBEQ38564991-445BD6F7-9C53-406D-8E72-EC058EA846A2Q38994567-84710C13-108F-4948-B241-871E49E8E43FQ40473772-CADABBEF-6E6C-4FC0-86B9-E9AB8B722322Q40584126-3E7B6950-ECC7-4EBE-8775-AF3AF627CA7BQ40663517-5CF32C87-451A-4CEB-848B-AF38F0AFB33BQ44734543-A7073A70-5C74-4D94-B43B-B2AE3B6CBE88Q47975293-C2F64254-011F-4A6D-86C6-BD29C35F370AQ48198817-AD998A04-09AA-4813-B385-02F390479A94Q50246623-21CE9BBB-E654-4CA4-97E3-A1715111C8C0Q50943026-AA2640DE-4FCE-4438-B366-D3963146A2C0Q51354491-C5E29B9F-B91F-4058-A2CF-0D8C58796D01Q52707854-39D75D29-3F56-4E77-BCB9-F0F7B7BC616FQ52714259-8B4AD7C5-76CA-4EED-8C5E-3A5A310FE705Q53290022-232C7969-1A0C-4F43-80A2-C622CFB9E239Q58693139-06AA9FA8-F8D6-41DD-8BB0-D3E94335F6DB
P2860
Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Animal models of complement-me ...... her lipid-based nanoparticles.
@ast
Animal models of complement-me ...... her lipid-based nanoparticles.
@en
type
label
Animal models of complement-me ...... her lipid-based nanoparticles.
@ast
Animal models of complement-me ...... her lipid-based nanoparticles.
@en
prefLabel
Animal models of complement-me ...... her lipid-based nanoparticles.
@ast
Animal models of complement-me ...... her lipid-based nanoparticles.
@en
P2093
P2860
P1476
Animal models of complement-me ...... her lipid-based nanoparticles.
@en
P2093
Carl R Alving
János Szebeni
Lajos Baranyi
László Rosivall
Miklós Tóth
Péter Bedöcs
Rolf Bünger
Yezheckel Barenholz
P2860
P304
P356
10.1080/08982100701375118
P577
2007-01-01T00:00:00Z